BMSN. Nice. POST. Excerpt from pharma and biotech review
BMSN. Nice. POST. Excerpt from pharma and biotech review , zachs research. Know what you hold here. Another quote from a very viable and noteworthy source. Huge potential with exactly the right business plan. See you on the up side real soon and be calm and patient. It will come to fruition.
Quote..."There has also been a significant pickup in in-licensing activities and collaborations for the development of pipeline candidates. Instead of developing a product from scratch, which involves a lot of funds, pharma companies are going shopping for mid-to late-stage pipeline candidates which look promising. As such, we would recommend investors to put their money in biotech stocks that have attractive pipeline candidates or technology that can be used for the development of novel therapeutics. Therapeutic areas which could see a lot of in-licensing activity include oncology, central nervous system disorders, diabetes and immunology/inflammation."
BMSN.
RIVULET MEDIA INC. (RIVU) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...
Continue Reading
Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....
Continue Reading
Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...
Continue Reading
A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...
Continue Reading
CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...
Continue Reading
University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...
Continue Reading
The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...
Continue Reading
PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...
Continue Reading
Top 5 Most Recently Viewed Articles
Steady Growth Amid Challenges for Synergie Q3 2025 Financial Overview In the face of challenging market conditions and a volatile geopolitical landscape, Synergie has reported a remarkable revenue achievement of €825.0 million for the third quarter of 2025. This marks an increase of +1.8% compared to the previous year, showcasing the resilience of the company's...
Continue Reading
Candace V. Fay's Unique Approach to Political Campaigning In the lively realm of politics, creativity can often spark engagement. Danbury City Council candidate Candace V. Fay exemplifies this with her innovative campaign, "Furever Danbury." This initiative aims to connect not just with voters but their beloved pets, making it a delightful twist in the political season....
Continue Reading
Texas Embraces Innovative Math Education with Savvas Learning Savvas Learning Company stands out as a leader in educational publishing, recently achieving a significant milestone in math education. The company's comprehensive line of K-12 math solutions, known as enVision+ Texas, has received approval for use in classrooms throughout Texas. This accomplishment reflects...
Continue Reading
TRX Gold Corporation Shows Strong Growth in Q2 2025 TRX Gold Corporation reported exciting results for the second quarter of 2025, which has brought a wave of optimism among investors and stakeholders. They showed a remarkable increase in revenue, operating cash flow, and a decrease in mining and processing costs compared to the previous year's figures. This significant...
Continue Reading
Introduction to a Major Real Estate Deal In a significant real estate move, Howard Lutnick, the CEO of Cantor Fitzgerald, is reportedly on the verge of purchasing Bret Baier's luxurious mansion in Washington, D.C. This estate, French-inspired and located in the prestigious Foxhall neighborhood, has garnered attention due to its price reduction from $31.9 million to $28.99...
Continue Reading